[recruitment of lung cancer patients] phase II clinical study on the treatment of high-risk advanced lung cancer with fu
[recruitment of lung cancer patients] phase II clinical study on the treatment of high-risk advanced lung cancer with furaquinidine
2020-04-21
Enterprise news | Chuangsheng group announced that its claudin18.2 humanized monoclonal antibody new drug tst001 was app
Enterprise news | Chuangsheng group announced that its claudin18.2 humanized monoclonal antibody new drug tst001 was approved by the US FDA to carry out clinical trials
2020-04-21
The latest global trend of DC vaccine research and development
The latest global trend of DC vaccine research and development
2020-04-20
Design, synthesis and activity evaluation of α - ketoamide derivatives as broad-spectrum inhibitors for coronaviruses an
Design, synthesis and activity evaluation of α - ketoamide derivatives as broad-spectrum inhibitors for coronaviruses and enteroviruses
2020-04-20
Guidelines for clinical trials of biological analogues for rituximab injection (Draft for comments)
Guidelines for clinical trials of biological analogues for rituximab injection (Draft for comments)
2020-04-18
First targeted therapy for cholangiocarcinoma! The oral FGFR inhibitor pemazyre (pemigatinib) of Incyte was approved by
First targeted therapy for cholangiocarcinoma! The oral FGFR inhibitor pemazyre (pemigatinib) of Incyte was approved by FDA
2020-04-18
Zhong Nanshan: two drugs are effective for new coronavirus!
Zhong Nanshan: two drugs are effective for new coronavirus!
2020-04-16
Thomas karalis, former general manager of new base Australia & New Zealand, was appointed market leader of Asia Pacific
Thomas karalis, former general manager of new base Australia & New Zealand, was appointed market leader of Asia Pacific region by Deqi pharmaceutical
2020-04-16
